Results 141 to 150 of about 245,105 (180)

Continuous Glucose Monitoring in the Management of Congenital Hyperinsulinism: A National User-satisfaction Survey, UK.

J Clin Endocrinol Metab
Couch H, Pearson A, Malhotra N, Ferguson M, Couch G, Gilbert C, Morgan K, Mann S, Cassidy K, Worthington S, O'Shea E, SalomonEstebanez M, Worth C, Senniappan S, Banerjee I, Dastamani A.   +15 more
europepmc   +1 more source

Mild Congenital Hyperinsulinism Caused by Mutation in Human Glucokinase Gene. [PDF]

JCEM Case Rep
Sozaeva LS, Ismailova SK, Chernyak IY, Popov SV, Zakharova VV, Chugunov IS.   +5 more
europepmc   +1 more source

Diazoxide toxicity in congenital hyperinsulinism: A case report.

World J Clin Pediatr
Pajno R, Visconti C, Bucolo C, Guarneri MP, Del Barba P, Silvani P, Gregnanin M, Barera G.   +7 more
europepmc   +1 more source

Low-Level Mosaic GCK Mutations in Children With Diazoxide-Unresponsive Congenital Hyperinsulinism.

J Clin Endocrinol Metab
Boodhansingh KE, Lord K, Adzick NS, Bhatti T, Ganguly A, Stanley CA, De Leon DD.   +6 more
europepmc   +1 more source

Congenital hyperinsulinism

Early Human Development, 2010
Congenital hyperinsulinism (CHI or HI) is a condition leading to recurrent hypoglycemia due to an inappropriate insulin secretion by the pancreatic islet beta cells. HI has two main characteristics: a high glucose requirement to correct hypoglycemia and a responsiveness of hypoglycemia to exogenous glucagon.
Klaus Mohnike, Yves Aigrain, Francis Brunelle   +2 more
exaly   +5 more sources

Glucose Metabolism in 105 Children and Adolescents After Pancreatectomy for Congenital Hyperinsulinism [PDF]

Diabetes Care, 2012
OBJECTIVE - To describe the long-term metabolic outcome of children with congenital hyperinsulinism after near-total or partial elective pancreatectomy.
Gilberto Velho, Jacques Beltrand, Francis Brunelle   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Congenital hyperinsulinism

Current Opinion in Pediatrics, 2013
Congenital hyperinsulinism (CHI) is a multifaceted disease and continues to be the most common cause of persistent hypoglycemia in infants. The purpose of the review is to highlight important recent developments regarding CHI.Several recent studies have highlighted the advances in medical genetics, imaging techniques, histological variety, and surgical
Vittoria Rufini, Milena Pizzoferro
openaire   +3 more sources

A Newborn with Congenital Hyperinsulinism

Fetal and Pediatric Pathology, 2019
Objective: Our aim was to describe the molecular alterations in the ABCC8 gene in a child with congenital hyperinsulinism (CHI). Methods: Genetic analysis of the ABCC8 gene of a newborn infant with congenial hyperinsulinism was obtained. Results: There were two mutations in the ABCC8 gene, c.4412delT, and c.3979G > A, indicating a compound heterozygous
Yiting, Du, Rong, Ju, Yufeng, Xi, Peng, Gou   +3 more
openaire   +2 more sources

Genetics of Congenital Hyperinsulinism

Endocrine Pathology, 2004
Congenital hyperinsulinism (CHI) is a clinically and genetically heterogeneous entity and causes severe hypoglycemia in neonates and infants. The clinical heterogeneity is manifested by severity ranging from extremely severe, life-threatening disease to very mild clinical symptoms, which may even be difficult to identify.
Jean-Christophe, Fournet, Claudine, Junien   +1 more
openaire   +2 more sources